Non-Small-Cell Lung Clinical Trials

24 clinical trials for Non-Small-Cell Lung across international registries, including 6 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• A Multi-centre Chart Review Study of Stage I-III Non-Small Cell Lung Cancer in China — RECRUITING
• Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC — RECRUITING · PHASE2
• Phase 1 Study of PF-08046033 in Advanced Solid Tumors — RECRUITING · PHASE1
• A Phase 1 Study of EPI-326 in EGFR-mutant NSCLC and HNSCC — RECRUITING · PHASE1
• Phase 2 Study for the Patient, Who Has Diagnosed With Small Cell Lung Cancer (SCLC) or Non Small Cell Lung Cancer (NSCLC) or Renal Cell Carcinoma (RCC) and Finished the First Line Stand Treatment , Need More Treatment — RECRUITING · PHASE2
• A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression — RECRUITING · PHASE1
• ADP-A2M4CD8 as Monotherapy or in Combination With Either Nivolumab or Pembrolizumab in HLA-A2+ Subjects With MAGE-A4 Positive Tumors (SURPASS) — ACTIVE_NOT_RECRUITING · PHASE1
• Savolitinib Plus Osimertinib Versus Platinum-based Doublet Chemotherapy in Participants With Non-Small Cell Lung Cancer Who Have Progressed on Osimertinib Treatment — ACTIVE_NOT_RECRUITING · PHASE3
• Impact of Radiotherapy-Immunotherapy Timing in NSCLC Brain Metastases — NOT_YET_RECRUITING
• A Study to Learn About Patients With Non-Small Cell Lung Cancer (NSCLC) Who Took Lorlatinib as Their First Treatment — ACTIVE_NOT_RECRUITING
• A Study of Neoadjuvant Atezolizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy in Patients With Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer (IMpower030) — COMPLETED · PHASE3
• A Study of Aflibercept Versus Placebo in Patients With Second-Line Docetaxel for Locally Advanced or Metastatic Non-Small-Cell Lung Cancer — COMPLETED · PHASE3
• A Clinica Study of Pyrotinib in Patients of Advanced Non-Small Cell Lung Cancer With HER2 Mutation — COMPLETED · PHASE2
• Study of Lorlatinib In People With ALK-positive Non-small Cell Lung Cancer — COMPLETED · PHASE4
• Phase III Study Evaluating Efficacy and Safety of Canakinumab in Combination With Docetaxel in Adult Subjects With Non-small Cell Lung Cancers as a Second or Third Line Therapy — TERMINATED · PHASE3
• A Study of HLX10 in Combination With Carboplatin Plus (+) Pemetrexed With or Without HLX04 Compared With Carboplatin+Pemetrexed in 1L Advanced Non-Squamous Non-Small Cell Lung Cancer (NSCLC) — OTHER · PHASE3
• First-line Replacement Maintenance of Envafolimab in Advanced NSCLC — OTHER · PHASE2
• Anlotinib Hydrochloride Combined With EGFR TKIs in Advanced Non-small Cell Lung Cancer — OTHER · NA
• Apatinib in the Treatment of Patients With EGFR T790M-Negative NSCLC — OTHER · PHASE2
• ZD6474(Vandetanib) + Alimta Combo Study — COMPLETED · PHASE1
• A 3rd/4th Line Placebo-controlled Trial of Sorafenib in Patients With Predominantly Non Squamous Non-Small Cell Lung Cancer (NSCLC). — COMPLETED · PHASE3
• Clinical Impact of EUS in Staging NSCLC — COMPLETED
• Iressa Expanded Access Program (EAP) — COMPLETED · PHASE3
• Safety Study of a Liposomal Docetaxel Formulation in Patients With Solid Tumors Who Have Failed Previous Therapies — COMPLETED · PHASE1

Refine this search